Loncar unveils China BioPharma Index

Loncar Investments introduced the Loncar China BioPharma Index (LCHINA), a global benchmark designed to track the performance of China’s biopharma industry.

The index will monitor the performance of publicly traded stocks listed on either Hong Kong Exchanges and Clearing Ltd. (HKEX) or NASDAQ, and will include pharmaceutical, biotech and diagnostics companies as well as drug manufacturers, wholesalers, distributors and service providers...